SLC5A2 and heart failure: Guidelines strongly recommend SGLT2 inhibitors and MRAs as part of the “Fantastic Four” for heart failure and reduced ejection fraction (HFrEF) [50] or the “Four Pillars” for DKD with albuminuria [51].